LY2452473 is primarily investigated for its potential therapeutic applications in the field of oncology. It functions as a selective inhibitor targeting specific pathways involved in cancer cell proliferation and survival. Research suggests its use in preclinical studies to evaluate its efficacy in treating various types of cancers, particularly those driven by the pathways it inhibits. Its application extends to understanding molecular mechanisms in cancer biology, aiding in the development of targeted therapies. Additionally, LY2452473 is utilized in experimental settings to assess its pharmacokinetics, safety profile, and potential for combination therapies with other anticancer agents.